Clinuvel股價目標被Wilsons下調4%,至A$30.16/股
道瓊斯08/30 07:23
Morgans Financial將Clinuvel Pharmaceuticals的評級從持有升級爲增持;目標價爲AU$16
MT Newswires08/23 16:43
Jefferies將Clinuvel Pharmaceuticals的目標價格下調14%,至39.70澳元/股。
道瓊斯08/22 11:56
摩根金融將Clinuvel藥品股票的評級從加入到持有降級;價格目標爲16澳元
MT Newswires07/08 15:35
摩根財務上調Clinuvel Pharmicals的持倉資格;目標股價爲16澳元
MT Newswires03/14 11:00
暫無數據